DouglasG.RogersMD

PubMed

• 5 citations
  Growth hormone treatment in a patient with Hurler-Scheie syndrome.
  Douglas Rogers, Nat Nasomyont
  Journal of Pediatric Endocrinology & Metabolism. 2014-09-20
• 4 citations
  Response to growth hormone treatment in a patient with 18p-syndrome
  Douglas Rogers, Ramachandra S. Aswini
  Journal of Pediatric Endocrinology & Metabolism. 2012-10-01
• 4 citations
  Herpesvirus Infections in Rock Hyraxes (Procavia Capensis)
  Judith A. Galeota, Julia E. Napier, Douglas L. Armstrong, Jean-Jack M Riethoven, Douglas G. Rogers
  Journal of Veterinary Diagnostic Investigation. 2009-07-01

Journal Articles

• Growth hormone treatment in a patient with Hurler-Scheie syndrome  
  Rogers DG, Nasomyont N, J Pediatr Endocrinol Metab, 5/13/2014
• Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth  
  Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers M, Schatz DA, Krischer JP, and the TEDDY, TRIGR, Diabetes Prevention Trial-Type..., Diabetes Care, 1/1/2012
• Fall in C-peptide Over First Two Years from Diagnosis: Evidence of At Least Two Distinct Phases from Composite TrialNet Data  
  Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM, Type 1 ..., Diabetes, 1/1/2012
• Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies  
  Yu L, Boulware DC, Beam CA, John C. Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL for the Type 1 Diabete..., Diabetes Care, 1/1/2012
• Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High Risk Population-Receiver Operating Characteristic Analysis  
  Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP and the DPT-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2012
• The Application of the Diabetes Prevention Trial Risk Score (DPTRS) for Identifying a Pre-Clinical State of Type 1 Diabetes  
  Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP, The TrialNet and Diabetes Prevention Tri..., Diabetes Care, 1/1/2012
• Response to growth hormone treatment in a patient with 18 P-syndrome  
  Rogers DG, Ramachandra SA, J Pediatric Endocrinology and Metabolism, 1/1/2012
• A Simplified Method for Screening Individuals at Risk of Developing Type 1 Diabetes Mellitus: An Assay for Combined Measurement of Three Autoantibodies (GADA, IA-2A an...  
  Siraj ES, Rogers DG, Gupta MK, Reddy SSK, Horm Metab Res, 1/1/2012
• Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Diabetes  
  Lachin J, Friedenberg-McGee P, Greenbaum CJ, Spain L, Palmer J, Pescovitz MD, Gottlieb P, Skyler J, for the Type 1 Diabetes TrialNet Study Group (Rogers DG-Study Group..., PLOS One, 1/1/2011
• A Longitudinal Study of GAD65 and ICA512 Autoantibodies during the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) Participants (Brief Report)  
  Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Cuthbertson D, Yu L, Schatz DA, Orban T, Eisenbarth G, Diabetes Prevention Trial-Type 1 and Type 1 Diabetes TrialNet Stu..., Diabetes Care, 1/1/2011
• The Validation of the Diabetes Prevention Trial-Type 1 RiskScore and the Detection of Pre-Diabetes in the TrialNet Natural History Study  
  Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP, the TrialNet and Diabetes Prevention Tri..., DiabetesCare, 1/1/2011
• Long Term Outcome of Individuals Treated with Oral Insulin: Diabetes Prevention Trial-Type 1 (DPT-1) Oral Insulin Trial  
  Vehik K, Cuthbertson D, Ruhling H, Schatz DA, Peakman M, Krischer JP, on behalf of the DPT-1 & TrialNet Study Groups (Rogers DG-Study Group Member), Diabetes Care, 1/1/2011
• Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for Repeat Screening Throughout Childhood  
  Vehik K, Haller MJ, Beam CA, Schatz DA, Wherrett DK, Sosenko JM, Krischer J, theDPT-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2011
• Comparison of Two Insulin Assays for First-Phase Insulin Release in Type 1 Diabetes Prediction and Prevention Studies  
  Mahon JL, Beam CA, Marcovina SM, Boulware DC, Palmer JP, Winter WE, Skyler JS, Krischer JP and the Type 1 Diabetes TrialNet Study Group (Rogers DG-Study Group Member), Clin Chim Acta, 1/1/2011
• Effect of Rituximab on Human In Vivo Antibody Immune Responses  
  Pescovitz M, Torgerson TR, Ochs HD, Ocheltree E, McGee P, Krause-Steinrauf H, Lachin JM, Canniff J, Greenbaum C, Herold KC, Skyler JS, Weinberg A, the Type 1 Diabetes ..., J Allergy Clin Immunol, 1/1/2011
• Increased T Cellular Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (Rituximab) Therapy in Type 1 Diabetes  
  Herold K, Pescovitz M, McGee P, Krause-Steinrauf H, Spain L, Bourcier K, Asare A, Liu Z, Lachin J, Dosch HM, for the Type 1 Diabetes TrialNet Study Group (Rogers DG-St..., J Immunology, 1/1/2011
• Development of Autoantibodies in the TrialNet Natural History Study (NHS)  
  Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP for the TrialNet Natural History Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2011
• Trends of Earlier and Later Responses of C-Peptide to Oral Glucose Challenges with Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants  
  Sosenko JM, Palmer JP, Rafkin LE, Krischer JP, Cuthbertson D, Greenbaum CJ, Eisenbarth GS, Skyler JS, and the DPT-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2010
• Progression to Diabetes in Relatives of Patients with Type 1 Diabetes: Mechanisms and Mode of Onset  
  Ferrannini E, Mari A, Nofrate V, Sosenko JM, Skyler JS, for the DPT-1 Study Group (Rogers DG-Study Group Member), Diabetes, 1/1/2010
• Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes  
  Xu P, Wu Y, Zhu Y, Dagne G, Johnson G, Cuthbertson D, Krischer J, Skyler J, Sosenko J, and the Diabetes Prevention Trial-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2010
• Glucose Excursions between States of Glycemia with Progression to Type 1 Diabetes in the Diabetes Prevention Trial Type 1 (DPT-1)  
  Sosenko J, Skyler J, Krischer J, Greenbaum C, Mahon J, Rafkin-Mervis L, Cuthbertson D, Cowie C, Herold K, Eisenbarth G, Palmer J, the Diabetes Prevention Trial-1 Study..., Diabetes, 1/1/2010
• Pancreatic Islet Cell Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1)  
  Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu L, Palmer JP, Schatz DA, Eisenbarth GS, and the DPT-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2009
• Validity and Reproducibility of Measurement of Islet Autoreactivity by T-cell Assays in Subjects with Early Type 1 Diabetes  
  Herold KC, Brooks-Worrell B, Palmer JP, Dosch HM, Peakman M, Gottlieb PA, Reijonen H, Arif S, Spain LM, Thompson C, Lachin JM, and The Type 1 Diabetes TrialNet Researc..., Diabetes, 1/1/2009
• The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results  
  Mahon J, Sosenko JM, Rafkin-Mervis LE, Krause-Steinrauf H, Lachin JM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J, Skyler JS, for the Tr..., Pediatric Diabetes, 1/1/2008
• Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes  
  Johnson SB, Baughcum AE, Rafkin-Mervis LE, Schatz DA, for the DPT-1 Study Group (Rogers DG-Study Group Member), Pediatric Diabetes, 1/1/2008
• Join now to see all

Books/Book Chapters

• Pediatric Gastrointestinal and Liver Disease 
  Chapter: Eating disorders and obesity. 
  Page 217 - 232Antonson DL, Rogers DG, Madison JKEditors: R Wyllie, JS Hyams.Elsevier, PhiladelphiaEdition 3rd,2006
• Clinical Preventive Medicine 
  Chapter: Prevention of diabetes mellitus. 
  Page 725 - 733Campbell JP, Rogers DGEditors: RS Lang, DD Hensrud.AMA Press, United States of AmericaEdition 2nd,2004
• The Cleveland Clinic Intensive Review of Pediatrics 
  Chapter: Thyroid disease. 
  Page 132 - 136Rogers DGEditors: C Sabella, RJ Cunningham III, DS Moodie.Lippincott Williams & Wilkins, Philadelphia2003
• The Cleveland Clinic Intensive Review of Pediatrics 
  Chapter: Short stature and growth hormone therapy. 
  Page 142 - 147Rogers DGEditors: C Sabella, RJ Cunningham III, DS Moodie.Lippincott Williams & Wilkins, Philadelphia2003
• Essence of Office Pediatrics 
  Chapter: Short stature, management. 
  Rogers DGEditors: JA Stockman III, JA Lohr.W.B. Saunders Company, Philadelphia2001
• The Science and Practice of Pediatric Cardiology 
  Chapter: Endocrinology: Consideration for the pediatric cardiologist. 
  Page 2491 - 2500Rogers DGEditors: A Garson, JT Bricker, DG McNamara.Lea and Febiger, Philadelphia1990
• Join now to see all

Abstracts/Posters

• Efficacy of 3 Day Blinded Continuous Glucose Monitoring System on HbA1c in Children and Adolescents with Type 1 Diabetes Mellitus.
  Rogers D, Haider A, Klein J, Aswini RS, Worley S, Pediatric Academic Societies' Annual Meeting, 1/1/2011
• Efficacy of 3 Day Blinded Continuous Glucose Monitoring System on HbA1c in Children and Adolescents with Type 1 Diabetes Mellitus.
  Rogers D, Klein J, Aswini RS, Worley S, American Association of Clinical Endocrinologist Annual Meeting, 1/1/2011
• Once-daily rhIGF-1 Treatment in Prepubertal Children with Primary IGFD: First-year Results from a Clinical Trial.
  Rogers D, Soyka L, Woods K, Frane J, Bright JM, Pediatric Academic Societies' Annual Meeting, 1/1/2009
• First-year height velocities with once-daily and twice-daily dosing of rhIGF-1 in two clinical trials of prepubertal dhildren with primary IGF-1 deficiency.
  Midyett LK, Rogers D, Hale D, Rogol A, Frane J, Bright GM, Endocrine Society Annual Meeting, 1/1/2009
• 15 Year Follow up Analysis of Parental Attitudes Toward Short Stature.
  Feldt M, MacLeish S, Rogers D, Silvers J, Cuttler L, Horm Res; LWPES-ESPE, 1/1/2009
• Safety and efficacy results of an 86-week, open-label study of PK-based, once-daily dosing of rhIGF-1 in children with primary IGF-1 deficiency.
  Rogers D, Gonzalez-Mendoza L, Soyka L, Frane J, Bright GM, LWPES ESPE, 1/1/2009
• Safety and Efficacy of Once-Daily rhIGF-1 Treatment in Prepubertal Children with Primary IGF-1 Deficiency: Results from a Clinical Trial.
  Bright G, Rogers D, Gonzalez Mendoza L, Frane J, ICE, 1/1/2008
• Screening for celiac and thyroid disease in pediatric patients with Down syndrome.
  Sammon B, Rogers D, Worley S, Tang A, Pediatric Academic Societies' Annual Meeting, 1/1/2008
• Experience with physiologic replacement dosing with recombinant human IGF-1(rhIGF-1) in pre-pubertal children with primary IGF-1 deficiency (IGFD).
  Moshang T, Rogers D, Frane J, Bright G, Endocrine Society Annual Meeting, 1/1/2007
• Final adult height in patients with constitutional delay of growth and puberty treated with oxandrolone.
  Bedocs LA, Rogers DG, Worley S, Pediatric Academic Societies' Annual Meeting, 1/1/2006
• Cholesterol/HDL ratio and Non-HDL cholesterol levels in children with type 1 diabetes mellitus: Correlation with glycemic control.
  Rahhal S, Rogers D, Worley S, Pediatric Academic Societies' Annual Meeting, 1/1/2005
• Prevalence of positive celiac disesase antibodies in children attending a pediatric endocrinology clinic.
  Lepejian G, Rogers D, Worley S, Cotman K, Pediatr Res, 1/1/2004
• Prevalence of positive celiac disesase antibodies in children attending a pediatric endocrinology clinic.
  Lepejian G, Rogers D, Worley S, Cotman K, Midwest Society for Pediatric Research, 44th Annual Meeting, 1/1/2003
• Comprehensive CYP21 genotyping for congenital adrenal hyperplasia.
  Vogel NM, Ford A, Rogers D, Witchel S, Dobrowolski S, Naylor E, Midwest Society for Pediatric Research, 43rd Annual Meeting, 1/1/2002
• A simple screening test for auto-antibodies associated with the development of type 1 diabetes: Measurement of GADA, IA-2A and IAA from capillary blood collected on fi...
  Siraj E, Rogers D, Gupta M, Switzer C, Knipper N, LWPES/ESPE 6th Joint Meeting, 1/1/2001
• A simple screening method for individuals at risk of developing type 1 diabetes: Measurement of islet cell auto-antibodies (GADA, IA-2A and IAA) on dried capillary blo...
  Siraj E, Rogers D, Gupta M, Reddy S, Arciaga R, Knipper N, 83rd Annual Meeting of the Endocrine Society, 1/1/2001
• Endogenous insulin retention by oral insulin in newly diagnosed antibody positive type-1 diabetes.
  Krischer J, Ten S, Marker J, Coutant R, Kukreja A, Zhong CH, Raskin P, Bode B, Vargas A, Rogers D, Schatz D, Deeb L, Marks J, Schwatz S, Malone J, Rappaporte R, Zeidle..., 61st Scientific Sessions, The American Diabetes Association, 1/1/2001
• The use of intravenous pamidronate to treat hypercalcemia due to subcutaneous fat necrosis.
  Khan N, Rogers DG, 10th symposium of the Polish Pediatric Endocrine Society, 1/1/2000
• Efficacy of different treatment modalities in children with acanthosis nigricans.
  Appachi M, Noel A, Rogers D, Midwest Society for Pediatric Research, 41st Annual Meeting, 1/1/2000
• Effects of recombinant human growth hormone therapy in pediatric patients with Crohn's disease.
  Laman D, Wyllie R, Rogers D, Balsells F, Sarigol S, Kay M, Am J Gastroenterol; American College of Gastroenterology, 1/1/1999
• Effects of recombinant human growth hormone therapy in pediatric patients with Crohn's disease.
  Laman D, Wyllie R, Rogers D, Balsells F, Sarigol S, Kay M, J Pediatr Gastroenterol Nutr; 13th Annual Meeting of the North American Society for Pediatric Gastroenterology and Nutrition, 1/1/1999
• Thyroxin therapy in children with primary and secondary hypothyroidism.
  Medina MP, Rogers DG, Maalouf N, Midwest Society for Pediatric Research 39th Annual Meeting, 1/1/1998
• Oral insulin therapy in newly-diagnosed immune mediated (type I) diabetes. Preliminary analysis of a randomized double blind placebo controlled study.
  Coutant R, Zeidler A, Rappaport R, Schatz D, Schwartz S, Malone J, Raskin P, Rogers D, Bode, B, Crockett S, Marks J, Deeb L, Chalew S, MacLaren N, 58th Scientific Sessions, The American Diabetes Association, 1/1/1998
• Thyroid dysfunction and fasting lipid profiles in children with Down's syndrome.
  Gertig T, Korman E, Rogers DG, 15th Annual Polish Endocrine Society Meetings, 1/1/1996
• Interactions between puberty and IDDM.
  Rogers DG, Brouhard BH, J Endocrinol Invest; 15th Annual Polish Endocrine Society Meetings, 1/1/1996
• Join now to see all

Lectures

• "Management of DKA." 
  Cleveland, OH - 10/1/2014
• Grand Rounds: "Evaluation and management of growth failure." 
  MetroHealth Medical Center Department of Pediatrics, Cleveland, OH - 9/18/2014
• "Polycystic ovary syndrome." 
  Cleveland Clinic, Cleveland, OH - 4/16/2014
• "Vascular complications of diabetes." 
  Cleveland Clinic, Cleveland, OH - 2/13/2014
• "Evaluation and management of growth failure." 
  Cleveland, OH - 2/7/2014
• Pediatric Grand Rounds: "Hyperlipidemia in Children." 
  Cleveland Clinic Foundation, Cleveland, OH - 2/4/2014
• "Metabolic Syndrome in Children." 
  Hillcrest Hospital, Cleveland, OH - 10/23/2013
• Internal Medicine Grand Rounds: "Insulin pumps and continuous glucose monitors." 
  St. Vincent Charity Medical Center, Cleveland, OH - 4/4/2013
• Pediatric Morbidity and Mortality Grand Rounds: "Disconnecting an insulin pump prior to a procedure." 
  Cleveland Clinic Foundation, Cleveland, OH - 4/2/2013
• "Disorders of puberty." 
  Cleveland, OH - 3/13/2013
• "Hyperlipidemia in Children." 
  Cleveland, OH - 2/15/2013
• "Starting new diabetics on insulin." 
  Cleveland, OH - 8/8/2012
• Adult Endocrine Grand Rounds: "Celiac Disease." 
  Cleveland Clinic, Cleveland, OH - 6/22/2012
• Internal Medicine Grand Rounds: "Metabolic Syndrome." 
  St. Vincent Charity Medical Center, Cleveland, OH - 6/15/2012
• Grand Rounds: "Insulin pumps and continuous glucose monitors." 
  MetroHealth Medical Center Department of Pediatrics, Cleveland, OH - 4/13/2012
• Grand Rounds: "Calcium and Vitamin D Disorders in Children." 
  Cleveland Clinic, Pediatric Institute, Cleveland, OH - 1/24/2012
• "Amenorrhea" 
  10/5/2011
• "Evaluation and management of short stature." 
  Cleveland, OH - 6/17/2011
• Grand Rounds: "Disorders of Puberty." 
  Hillcrest Hospital Department of Pediatrics, Mayfield Heights, OH - 5/6/2011
• "Calcium and Vitamin D Disorders in Children." 
  Beachwood, OH - 4/30/2011
• Grand Rounds: "Diabetic Ketoacidosis in Children." 
  4/6/2011
• "Diabetes in Children." 
  Cleveland, OH - 4/4/2011
• "Puberty disorders." 
  4/1/2011
• Pediatric Grand Rounds: "Celiac Disease." 
  Michigan State University, Kalamazoo Center for Medical Studies - 3/18/2011
• "Celiac Disease." 
  Cleveland, OH - 3/16/2011
• Join now to see all

Other

• Web Chat: "Diabetes in children." 
  Douglas George Rogers, MD
  Cleveland Clinic, Cleveland OH - 6/20/2012
• Diabetes Mellitus Type 2 in Children. 
  Rogers DG, First Consult
  http://www.firstconsult.com/das/pdxmd/body/404608577-54/0?type=med&eid=9-u1.0-_1_mt_1011045&tab=T
  1/1/2012
• NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. 
  Rogers DG (Consensus Panel Member)
  http://www.consensus.nih.gov/2006/MVMDRAFT051706.pdf
  5/15/2006
• "NIH consensus panel: Celiac disease" 
  Rogers DG
  http://consensus.nih.gov/cons/118/118celiacPDF.pdf
  1/1/2004
• "Short Stature." 
  Douglas George Rogers, MD, Family Practice, Audio-Digest, Vol.44, No. 41
  11/4/1996
• "Thyroid disease-How and when to evaluate." 
  Douglas George Rogers, MD, Audio-Digest Foundation, Vol.41, No. 20
  10/24/1995
• "Growth hormone-Use and abuse." 
  Douglas George Rogers, MD, Audio-Digest Foundation, Vol.41, No. 20
  10/24/1995
• Join now to see all